ASMB
Assembly Biosciences·NASDAQ
--
--(--)
--
--(--)
ASMB fundamentals
During Q4 2025, Assembly Biosciences (ASMB) reported revenue of 42.47M, a YoY change of 477.26%. Net income was 22.09M, a YoY change of 313.74%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2015 | Q3,2015 | Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Apr 1, 2015 | Jul 1, 2015 | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2015 | Sep 30, 2015 | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 684.37K -- | 2.36M -- | 2.66M -- | 3.32M -- | 3.56M +420.92% | 3.22M +36.40% | 4.29M +61.15% | 3.73M +12.65% | 3.88M +8.98% | 3.08M -4.29% | 4.23M -1.28% | 4.77M +27.60% | 4.08M +5.05% | 39.38M +1178.44% | 34.61M +718.03% | 1.04M -78.24% | -- -- | -- -- | 6.25M -81.93% | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 7.16M -- | 5.79M -- | 8.53M -- | 6.84M -- | 7.36M +2.71% | 9.42M +62.82% | 9.63M +12.81% | 10.79M +57.62% | 42.47M +477.26% | 72.30M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 684.37K -- | 2.36M -- | 2.66M -- | 3.32M -- | 3.56M +420.92% | 3.22M +36.40% | 4.29M +61.15% | 3.73M +12.65% | 3.88M +8.98% | 3.08M -4.29% | 4.23M -1.28% | 4.77M +27.60% | 4.08M +5.05% | 39.38M +1178.44% | 34.61M +718.03% | 1.04M -78.24% | -- -- | -- -- | 6.25M -81.93% | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 7.16M -- | 5.79M -- | 8.53M -- | 6.84M -- | 7.36M +2.71% | 9.42M +62.82% | 9.63M +12.81% | 10.79M +57.62% | 42.47M +477.26% | 72.30M -- |
Cost of Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 684.37K -- | 2.36M -- | 2.66M -- | -5.70M -- | 3.56M +420.92% | 3.22M +36.40% | 4.29M +61.15% | -11.07M -94.08% | 3.88M +8.98% | 3.08M -4.29% | 4.23M -1.28% | -11.20M -1.16% | 4.08M +5.05% | 39.38M +1178.44% | 34.61M +718.03% | -78.07M -597.22% | -- -- | -- -- | 6.25M -81.93% | -6.25M +91.99% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 7.15M -- | 7.12M -- | 8.18M -- | 11.28M -- | 10.45M +46.13% | 11.68M +63.98% | 11.87M +45.15% | 14.61M +29.59% | 15.93M +52.35% | 15.11M +29.38% | 15.60M +31.41% | 20.24M +38.47% | 30.38M +90.78% | 26.86M +77.77% | 30.06M +92.73% | 32.22M +59.22% | 22.78M -25.03% | 30.22M +12.52% | 33.45M +11.29% | 31.77M -1.38% | 32.80M +43.97% | 38.63M +27.81% | 40.68M +21.61% | 27.26M -14.22% | 23.67M -27.84% | 25.13M -34.95% | 62.89M +54.60% | 23.16M -15.03% | 24.57M +3.83% | 23.40M -6.88% | 22.98M -63.46% | 19.56M -15.56% | 17.49M -28.83% | 15.05M -35.70% | 19.71M -14.20% | 16.51M -15.57% | 20.74M +18.57% | 17.80M +18.29% | 18.89M -4.18% | 19.36M +17.23% | 20.72M -0.08% | 21.67M +21.75% | 22.67M +20.02% | 84.42M -- |
Selling, General and Administrative Expenses | 2.49M -- | 2.49M -- | 2.95M -- | 3.16M -- | 2.94M +18.06% | 2.85M +14.20% | 3.25M +9.99% | 4.04M +27.92% | 3.80M +29.52% | 4.18M +46.89% | 5.00M +54.02% | 5.70M +40.97% | 12.54M +229.97% | 7.75M +85.44% | 8.81M +76.17% | 9.52M +67.08% | 4.08M -67.47% | 8.49M +9.49% | 10.83M +23.03% | 8.73M -8.28% | 9.47M +132.11% | 11.69M +37.71% | 7.17M -33.82% | 8.70M -0.29% | 6.92M -26.96% | 6.66M -43.07% | 6.50M -9.29% | 5.96M -31.56% | 6.78M -1.97% | 5.27M -20.80% | 6.13M -5.83% | 5.01M -15.86% | 4.96M -26.78% | 4.22M -19.86% | 8.71M +42.17% | 4.63M -7.52% | 4.48M -9.83% | 4.29M +1.47% | 4.61M -47.07% | 4.51M -2.72% | 4.59M +2.61% | 5.08M +18.64% | 5.42M +17.60% | 19.61M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 12.19M -- | -- -- | -- -- | -- -- | 17.02M +39.69% | -- -- | -- -- | -- -- | 34.80M +104.44% | -- -- | -- -- | -- -- | 32.92M -5.40% | -- -- | -- -- | -- -- | 37.06M +12.57% | -- -- | -- -- | -- -- | 28.78M -22.34% | -- -- | -- -- | -- -- | 24.13M -16.14% | -- -- | -- -- | 4.22M -- | 8.71M -63.92% | 4.63M -- | 4.48M -- | 4.29M +1.47% | 4.61M -47.07% | 4.51M -2.72% | 4.59M +2.61% | 5.08M +18.64% | 5.42M +17.60% | 19.61M -- |
Research and Development Expenses | 4.67M -- | 4.63M -- | 5.23M -- | 8.12M -- | 7.52M +61.08% | 8.83M +90.77% | 8.62M +65.00% | 10.57M +30.24% | 12.13M +61.26% | 10.93M +23.73% | 10.60M +22.90% | 14.54M +37.52% | 17.84M +47.13% | 19.11M +74.84% | 21.25M +100.54% | 22.70M +56.14% | 18.70M +4.82% | 21.74M +13.75% | 22.62M +6.42% | 23.05M +1.51% | 23.33M +24.74% | 26.94M +23.95% | 33.51M +48.17% | 18.55M -19.49% | 16.75M -28.20% | 18.47M -31.43% | 14.75M -55.99% | 17.20M -7.27% | 17.79M +6.23% | 18.13M -1.86% | 16.85M +14.28% | 14.55M -15.45% | 12.52M -29.61% | 10.82M -40.30% | 11.01M -34.69% | 11.88M -18.34% | 16.26M +29.83% | 13.52M +24.86% | 14.28M +29.75% | 14.85M +25.02% | 16.13M -0.82% | 16.59M +22.73% | 17.25M +20.80% | 64.81M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 41.64M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -7.15M -- | -7.12M -- | -8.18M -- | -11.28M -- | -10.45M -46.13% | -11.68M -63.98% | -11.87M -45.15% | -13.93M -23.52% | -13.57M -29.78% | -12.45M -6.60% | -12.28M -3.47% | -16.67M -19.69% | -27.17M -100.23% | -22.57M -81.32% | -26.32M -114.35% | -28.34M -69.96% | -19.70M +27.48% | -25.99M -15.14% | -28.68M -8.97% | -27.69M +2.27% | 6.58M +133.40% | -4.02M +84.54% | -39.64M -38.20% | -27.26M +1.57% | -23.67M -459.72% | -18.88M -369.64% | -62.89M -58.64% | -23.16M +15.03% | -24.57M -3.83% | -23.40M -23.98% | -22.98M +63.46% | -19.56M +15.56% | -17.49M +28.83% | -15.05M +35.70% | -12.55M +45.38% | -10.73M +45.15% | -12.20M +30.22% | -10.96M +27.19% | -11.53M +8.12% | -9.94M +7.34% | -11.09M +9.10% | -10.88M +0.67% | 19.80M +271.69% | -12.12M -- |
Non-Operating Income (Loss) | 211.23K -- | 504.29K -- | 428.00K -- | 288.59K -- | 301.93K +42.94% | 104.81K -79.22% | -296.33K -169.24% | -764 -100.26% | -101.13K -133.49% | 142.26K +35.73% | 327.63K +210.56% | 423.00K +55466.49% | 326.00K +422.37% | 1.03M +626.85% | 1.30M +296.79% | 1.28M +201.89% | 1.19M +263.80% | 983.00K -4.93% | 859.00K -33.92% | 1.04M -18.64% | 691.00K -41.74% | 670.00K -31.84% | 224.00K -73.92% | 58.00K -94.42% | 71.00K -89.73% | 72.00K -89.25% | 101.00K -54.91% | 71.00K +22.41% | 112.00K +57.75% | 256.00K +255.56% | 583.00K +477.23% | 609.00K +757.75% | 592.00K +428.57% | 628.00K +145.31% | 1.62M +178.22% | 1.65M +171.26% | 1.46M +146.11% | 1.34M +113.85% | 1.12M -30.89% | 1.12M -32.02% | 895.00K -38.57% | 1.69M +25.61% | 2.29M +104.37% | 6.00M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.14M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | 211.23K -- | 504.29K -- | 428.00K -- | 288.59K -- | 301.93K +42.94% | 104.81K -79.22% | -695.33K -262.46% | -764 -100.26% | -101.13K -133.49% | 142.26K +35.73% | -655.37K +5.75% | 423.00K +55466.49% | 326.00K +422.37% | 1.03M +626.85% | -1.78M -172.06% | 1.28M +201.89% | 1.19M +263.80% | 983.00K -4.93% | -3.45M -93.27% | 1.04M -18.64% | 691.00K -41.74% | 670.00K -31.84% | 224.00K +106.50% | 58.00K -94.42% | 71.00K -89.73% | 72.00K -89.25% | 101.00K -54.91% | 71.00K +22.41% | 112.00K +57.75% | 256.00K +255.56% | 583.00K +477.23% | 609.00K +757.75% | 592.00K +428.57% | -- -- | 3.45M +491.94% | -- -- | -- -- | -- -- | 5.57M +61.49% | -- -- | -- -- | -- -- | 6.00M +7.59% | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.54M -- | -- -- | -- -- | -- -- | -983.00K +36.13% | -- -- | -- -- | -- -- | -3.08M -213.63% | -- -- | -- -- | -- -- | -4.30M -39.64% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -628.00K -- | 1.83M -- | -1.65M -- | -1.46M -- | -1.34M -113.85% | 4.45M +143.41% | -1.12M +32.02% | -895.00K +38.57% | -1.69M -25.61% | 3.71M -16.78% | -- -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.54M -- | -- -- | -- -- | -- -- | 983.00K -36.13% | -- -- | -- -- | -- -- | 3.08M +213.63% | -- -- | -- -- | -- -- | 4.30M +39.64% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 628.00K -- | -1.83M -- | 1.65M -- | 1.46M -- | 1.34M +113.85% | -4.45M -143.41% | 1.12M -32.02% | 895.00K -38.57% | 1.69M +25.61% | -3.71M +16.78% | -- -- |
Pretax Income From Continuing Operations | -6.94M -- | -6.62M -- | -7.75M -- | -10.99M -- | -10.15M -46.23% | -11.57M -74.89% | -12.16M -56.99% | -13.93M -26.77% | -13.67M -34.63% | -12.31M -6.34% | -11.95M +1.74% | -16.25M -16.64% | -26.84M -96.37% | -21.54M -75.02% | -25.02M -109.35% | -27.06M -66.53% | -18.51M +31.02% | -25.01M -16.10% | -27.82M -11.20% | -26.66M +1.49% | 7.27M +139.27% | -3.35M +86.61% | -39.42M -41.66% | -27.20M -2.04% | -23.59M -424.55% | -18.80M -461.45% | -62.79M -59.29% | -23.09M +15.11% | -24.46M -3.67% | -23.14M -23.09% | -22.39M +64.33% | -18.95M +17.93% | -16.90M +30.93% | -14.42M +37.70% | -10.93M +51.20% | -9.08M +52.10% | -10.75M +36.40% | -9.61M +33.34% | -10.41M +4.74% | -8.82M +2.85% | -10.20M +5.10% | -9.20M +4.34% | 22.09M +312.18% | -6.12M -- |
Income Tax Expense | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | -618.00K -- | -- -- | -69.51K -- | -35.90K -- | -8.94M -1347.34% | 0 -- | -34.00K +51.09% | -6.00K +83.29% | 1.14M +112.73% | -7.00K -- | -11.00K +67.65% | -15.00K -150.00% | -741.00K -165.06% | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | -2.53M -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | 33.00K -- | -- -- | 406.00K -- | -- -- | -76.00K -330.30% | -- -- | -- -- | -- -- | -- -- | -- -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 33.00K -- | -- -- | -- -- | -- -- | 330.00K +900.00% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -2.53M -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -6.94M -- | -6.62M -- | -7.75M -- | -10.99M -- | -10.15M -46.23% | -11.57M -74.89% | -11.55M -49.02% | -13.93M -26.77% | -13.60M -33.95% | -12.27M -6.03% | -3.01M +73.95% | -16.25M -16.64% | -26.81M -97.12% | -21.54M -75.48% | -26.16M -769.85% | -27.05M -66.48% | -18.50M +30.97% | -25.00M -16.07% | -27.08M -3.53% | -26.66M +1.47% | 7.27M +139.29% | -3.35M +86.60% | -39.42M -45.54% | -27.20M -2.04% | -23.59M -424.55% | -18.80M -461.45% | -60.26M -52.87% | -23.09M +15.11% | -24.46M -3.67% | -23.14M -23.09% | -22.39M +62.83% | -18.95M +17.93% | -16.90M +30.93% | -14.42M +37.70% | -10.96M +51.05% | -9.08M +52.10% | -11.15M +34.00% | -9.61M +33.34% | -10.34M +5.72% | -8.82M +2.85% | -10.20M +8.55% | -9.20M +4.34% | 22.09M +313.74% | -6.12M -- |
Net Income Attributable to Owners of the Company | -6.94M -- | -6.62M -- | -7.75M -- | -10.99M -- | -10.15M -46.23% | -11.57M -74.89% | -11.55M -49.02% | -13.93M -26.77% | -13.60M -33.95% | -12.27M -6.03% | -3.01M +73.95% | -16.25M -16.64% | -26.81M -97.12% | -21.54M -75.48% | -26.16M -769.85% | -27.05M -66.48% | -18.50M +30.97% | -25.00M -16.07% | -27.08M -3.53% | -26.66M +1.47% | 7.27M +139.29% | -3.35M +86.60% | -39.42M -45.54% | -27.20M -2.04% | -23.59M -424.55% | -18.80M -461.45% | -60.26M -52.87% | -23.09M +15.11% | -24.46M -3.67% | -23.14M -23.09% | -22.39M +62.83% | -18.95M +17.93% | -16.90M +30.93% | -14.42M +37.70% | -10.96M +51.05% | -9.08M +52.10% | -11.15M +34.00% | -9.61M +33.34% | -10.34M +5.72% | -8.82M +2.85% | -10.20M +8.55% | -9.20M +4.34% | 22.09M +313.74% | -6.12M -- |
Net Income Attributable to Common Stockholders | -6.94M -- | -6.62M -- | -7.75M -- | -10.99M -- | -10.15M -46.23% | -11.57M -74.89% | -11.55M -49.02% | -13.93M -26.77% | -13.60M -33.95% | -12.27M -6.03% | -3.01M +73.95% | -16.25M -16.64% | -26.81M -97.12% | -21.54M -75.48% | -26.16M -769.85% | -27.05M -66.48% | -18.50M +30.97% | -25.00M -16.07% | -27.08M -3.53% | -26.66M +1.47% | 7.27M +139.29% | -3.35M +86.60% | -39.42M -45.54% | -27.20M -2.04% | -23.59M -424.55% | -18.80M -461.45% | -60.26M -52.87% | -23.09M +15.11% | -24.46M -3.67% | -23.14M -23.09% | -22.39M +62.83% | -18.95M +17.93% | -16.90M +30.93% | -14.42M +37.70% | -10.96M +51.05% | -9.08M +52.10% | -11.15M +34.00% | -9.61M +33.34% | -10.34M +5.72% | -8.82M +2.85% | -10.20M +8.55% | -9.20M +4.34% | 22.09M +313.74% | -6.12M -- |
Other Comprehensive Income | -134.22K -- | -253.66K -- | -433.71K -- | 72.09K -- | -89.87K +33.04% | 2.79K +101.10% | 235.98K +154.41% | 76.09K +5.55% | 126.41K +240.66% | 9.88K +253.54% | -3.38K -101.43% | -67.00K -188.05% | 87.00K -31.18% | 17.00K +72.10% | 8.00K +336.69% | 108.00K +261.19% | 52.00K -40.23% | -18.00K -205.88% | 4.00K -50.00% | 115.00K +6.48% | 190.00K +265.38% | -262.00K -1355.56% | -112.00K -2900.00% | -1.00K -100.87% | -2.00K -101.05% | -15.00K +94.27% | -131.00K -16.96% | -489.00K -48800.00% | -90.00K -4400.00% | -1.00K +93.33% | 196.00K +249.62% | 290.00K +159.30% | 188.00K +308.89% | 50.00K +5100.00% | 194.00K -1.02% | -158.00K -154.48% | -54.00K -128.72% | 137.00K +174.00% | -55.00K -128.35% | -42.00K +73.42% | -26.00K +51.85% | 189.00K +37.96% | 49.00K +189.09% | 170.00K -- |
Total Comprehensive Income | -7.08M -- | -6.87M -- | -8.18M -- | -10.92M -- | -10.24M -44.73% | -11.57M -68.39% | -11.31M -38.23% | -13.85M -26.91% | -13.47M -31.54% | -12.26M -5.97% | -3.01M +73.38% | -16.32M -17.77% | -26.72M -98.32% | -21.52M -75.48% | -26.15M -768.61% | -26.94M -65.14% | -18.45M +30.94% | -25.01M -16.24% | -27.08M -3.54% | -26.54M +1.50% | 7.46M +140.43% | -3.61M +85.56% | -39.53M -45.97% | -27.20M -2.49% | -23.60M -416.31% | -18.82M -421.13% | -60.39M -52.76% | -23.58M +13.31% | -24.55M -4.04% | -23.15M -23.00% | -22.20M +63.24% | -18.66M +20.87% | -16.71M +31.95% | -14.37M +37.92% | -10.77M +51.49% | -9.23M +50.51% | -11.21M +32.93% | -9.48M +34.06% | -10.39M +3.51% | -8.86M +4.06% | -10.22M +8.76% | -9.01M +4.95% | 22.14M +313.08% | -5.95M -- |
Total Comprehensive Income Attributable to Owners of the Company | -7.08M -- | -6.87M -- | -8.18M -- | -10.92M -- | -10.24M -44.73% | -11.57M -68.39% | -11.31M -38.23% | -13.85M -26.91% | -13.47M -31.54% | -12.26M -5.97% | -3.01M +73.38% | -16.32M -17.77% | -26.72M -98.32% | -21.52M -75.48% | -26.15M -768.61% | -26.94M -65.14% | -18.45M +30.94% | -25.01M -16.24% | -27.08M -3.54% | -26.54M +1.50% | 7.46M +140.43% | -3.61M +85.56% | -39.53M -45.97% | -27.20M -2.49% | -23.60M -416.31% | -18.82M -421.13% | -60.39M -52.76% | -23.58M +13.31% | -24.55M -4.04% | -23.15M -23.00% | -22.20M +63.24% | -18.66M +20.87% | -16.71M +31.95% | -14.37M +37.92% | -10.77M +51.49% | -9.23M +50.51% | -11.21M +32.93% | -9.48M +34.06% | -10.39M +3.51% | -8.86M +4.06% | -10.22M +8.76% | -9.01M +4.95% | 22.14M +313.08% | -5.95M -- |
Basic EPS | -0.41 -- | -0.38 -- | -0.45 -- | -0.64 -- | -0.59 -43.90% | -0.67 -76.32% | -0.67 -48.89% | -0.81 -26.56% | -0.78 -32.20% | -0.71 -5.97% | -0.15 +77.61% | -0.8 +1.23% | -1.3 -66.67% | -0.87 -22.54% | -1.03 -586.67% | -1.05 -31.25% | -0.72 +44.62% | -0.96 -10.34% | -0.83 +19.42% | -0.76 +27.62% | 0.21 +129.17% | -0.09 +90.63% | -1.16 -39.76% | -0.69 +9.21% | -0.55 -361.90% | -0.41 -355.56% | -1.25 -7.76% | -0.48 +30.43% | -0.51 +7.27% | -0.48 -17.07% | -0.46 +63.20% | -4.46 -829.17% | -3.88 -660.78% | -3.29 -585.42% | -0.17 +63.04% | -1.66 +62.78% | -1.98 +48.97% | -1.51 +54.10% | -1.39 -717.65% | -1.17 +29.52% | -1.33 +32.83% | -0.72 +52.32% | 1.39 +200.00% | -1.83 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.29 -- | -- -- | -1.66 -- | -1.98 -- | -1.51 +54.10% | -- -- | -1.17 +29.52% | -1.33 +32.83% | -0.72 +52.32% | -- -- | -- -- |
Diluted EPS | -0.41 -- | -0.38 -- | -- -- | -0.64 -- | -0.59 -43.90% | -0.67 -76.32% | -- -- | -0.81 -26.56% | -0.78 -32.20% | -0.71 -5.97% | -- -- | -0.8 +1.23% | -1.3 -66.67% | -0.87 -22.54% | -- -- | -1.05 -31.25% | -0.72 +44.62% | -0.96 -10.34% | -- -- | -0.76 +27.62% | 0.19 +126.39% | -0.09 +90.63% | -- -- | -0.69 +9.21% | -0.55 -389.47% | -0.41 -355.56% | -- -- | -0.48 +30.43% | -0.51 +7.27% | -0.48 -17.07% | -- -- | -4.46 -829.17% | -3.88 -660.78% | -3.29 -585.42% | -- -- | -1.66 +62.78% | -1.98 +48.97% | -1.51 +54.10% | -- -- | -1.17 +29.52% | -1.33 +32.83% | -0.72 +52.32% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.29 -- | -- -- | -1.66 -- | -1.98 -- | -1.51 +54.10% | -- -- | -1.17 +29.52% | -1.33 +32.83% | -0.72 +52.32% | -- -- | -- -- |
You can ask Aime
What were the key takeaways from Assembly Biosciences's earnings call?What is the market's earnings forecast for Assembly Biosciences next quarter?What is the revenue and EPS growth rate for Assembly Biosciences year over year?What guidance did Assembly Biosciences's management provide for the next earnings period?What were the key takeaways from Assembly Biosciences’s earnings call?Did Assembly Biosciences beat or miss consensus estimates last quarter?What is Assembly Biosciences's latest dividend and current dividend yield?What does Assembly Biosciences do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
